Echo Therapeutics (ECTE) Reports Q3 Loss of $0.16/Share

Go back to Echo Therapeutics (ECTE) Reports Q3 Loss of $0.16/Share

Form 10-Q Echo Therapeutics, Inc. For: Sep 30

November 16, 2015 4:26 PM EST

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC... More